[Market Focus] SK Biopharmaceuticals Soars 17% on Earnings Surprise

SK Biopharmaceuticals is experiencing a stock rally on August 5, driven by earnings that exceeded market expectations.

As of 10:05 a.m. on this day, SK Biopharmaceuticals is trading at 112,900 won per share, up 17.48% from the previous trading day.

This surge is attributed to strong buying activity following the company's announcement that its consolidated operating profit for the second quarter of this year was provisionally tallied at 61.9 billion won, a 137.6% increase compared to the same period last year.

This figure far surpasses the market forecast of 37.5 billion won. Second-quarter revenue and net profit also rose by 31.6% and 20.2%, respectively, reaching 176.3 billion won and 29.5 billion won.

This content was produced with the assistance of AI translation services.